In Cough X Par 100 mg/2.5 mg Tablet gives relief from cough by loosening thick mucus and making it easier to cough it out. It also makes it easier for air to move in and out of your airways. This reduces the frequency of coughing and makes you feel better. With the use of X Par 100 mg/2.5 mg Tablet as prescribed by the doctor, you can get relief from cough sooner. Along with medications, drink enough lukewarm water and gargle with warm salt water to ease the symptoms.
It is not known whether it is safe to consume alcohol with X Par 100 mg/2.5 mg Tablet. Please consult your doctor.
X Par 100 mg/2.5 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
X Par 100 mg/2.5 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
X Par 100 mg/2.5 mg Tablet does not usually affect your ability to drive.
X Par 100 mg/2.5 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of X Par 100 mg/2.5 mg Tablet may be needed. Please consult your doctor.
X Par 100 mg/2.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of X Par 100 mg/2.5 mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of X Par 100 mg/2.5 mg Tablet in these patients.
If you miss a dose of X Par 100 mg/2.5 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: AstraZeneca || ₹14.5/tablet (25% cheaper)